These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21411362)

  • 1. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011).
    Marcuzzi A; Zanin V; Crovella S; Pontillo A
    Oral Oncol; 2011 May; 47(5):436-7; author reply 438. PubMed ID: 21411362
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonate-associated osteonecrosis: experiences in a private practice.
    Marder MZ; Marder RW
    Dent Today; 2008 Oct; 27(10):99-100, 102-3; quiz 103, 98. PubMed ID: 18935863
    [No Abstract]   [Full Text] [Related]  

  • 4. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
    Tsai KY; Huang CS; Huang GM; Yu CT
    J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing the adverse effects of bisphosphonate therapy on the jaw.
    Rizzolo D; Sedrak M
    JAAPA; 2009 Nov; 22(11):48-52. PubMed ID: 19999176
    [No Abstract]   [Full Text] [Related]  

  • 6. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D; Shetty S; Ashworth D; Grew N; Millar B
    Br Dent J; 2007 Jul; 203(2):91-2. PubMed ID: 17660779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse oral sequelae to bisphosphonate administration.
    Marunick M; Miller R; Gordon S
    J Mich Dent Assoc; 2005 Nov; 87(11):44-9. PubMed ID: 16372548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate associated osteonecrosis of the jaw; similarities and differences in oncologic and non-oncologic patients.
    Chogle AR
    J Assoc Physicians India; 2011 Aug; 59():477-8. PubMed ID: 21887901
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series.
    Epstein MS; Wicknick FW; Epstein JB; Berenson JR; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):593-6. PubMed ID: 20955948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification".
    Woo SB; Mawardi H; Treister N
    Oral Oncol; 2009 Aug; 45(8):740. PubMed ID: 19038574
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis: what does it mean? One condition partly caused by bisphosphonates--or another one, preferably treated with them?
    Aspenberg P
    Acta Orthop; 2006 Oct; 77(5):693-4. PubMed ID: 17068696
    [No Abstract]   [Full Text] [Related]  

  • 15. The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line.
    Assael LA
    J Oral Maxillofac Surg; 2007 Jul; 65(7):1275-6. PubMed ID: 17577488
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kyrgidis A; Vahtsevanos K
    J Craniomaxillofac Surg; 2011 Jun; 39(4):271. PubMed ID: 20434920
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonate osteonecrosis of the jaws in cancer patients.
    Kyrgidis A; Andreadis C
    Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
    [No Abstract]   [Full Text] [Related]  

  • 18. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonate associated osteonecrosis of the jaws and endodontic treatment: two case reports.
    Fugazzotto PA; Lightfoot S
    J Mass Dent Soc; 2006; 55(2):5. PubMed ID: 16937899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.